Patient‐reported symptoms and discontinuation of adjuvant aromatase inhibitor therapyKelley M. Kidwell, N. Lynn Henry, Steven E. Harte et al.|Cancer|2014Cited by 98
Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast CancerKunal C. Kadakia, N. Lynn Henry, Kelley M. Kidwell et al.|The Oncologist|2016Cited by 76
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancerN. Lynn Henry, David A. Flockhart, Todd C. Skaar et al.|Breast Cancer Research and Treatment|2013Cited by 64
Modeling hot flushes and quality of life in breast cancer survivorsKevin L. Rand, Janet S. Carpenter, Julie L. Otte et al.|Climacteric|2010Cited by 54
Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapyJulie L. Otte, Janet S. Carpenter, David A. Flockhart et al.|Menopause The Journal of The North American Menopause Society|2009Cited by 27